BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 1383148)

  • 1. WI-1, a novel 120-kilodalton surface protein on Blastomyces dermatitidis yeast cells, is a target antigen of cell-mediated immunity in human blastomycosis.
    Klein BS; Sondel PM; Jones JM
    Infect Immun; 1992 Oct; 60(10):4291-300. PubMed ID: 1383148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-Cell epitopes and human leukocyte antigen restriction elements of an immunodominant antigen of Blastomyces dermatitidis.
    Chang WL; Audet RG; Aizenstein BD; Hogan LH; DeMars RI; Klein BS
    Infect Immun; 2000 Feb; 68(2):502-10. PubMed ID: 10639410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic recognition of a 25-amino acid repeat arrayed in tandem on a major antigen of Blastomyces dermatitidis.
    Klein BS; Hogan LH; Jones JM
    J Clin Invest; 1993 Jul; 92(1):330-7. PubMed ID: 8326001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation, purification, and radiolabeling of a novel 120-kD surface protein on Blastomyces dermatitidis yeasts to detect antibody in infected patients.
    Klein BS; Jones JM
    J Clin Invest; 1990 Jan; 85(1):152-61. PubMed ID: 2295693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and protective efficacy of the WI-1 adhesin of Blastomyces dermatitidis.
    Wüthrich M; Chang WL; Klein BS
    Infect Immun; 1998 Nov; 66(11):5443-9. PubMed ID: 9784555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of the major antigen WI-1 from Blastomyces dermatitidis yeasts and immunological comparison with A antigen.
    Klein BS; Jones JM
    Infect Immun; 1994 Sep; 62(9):3890-900. PubMed ID: 7520423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blastomyces dermatitidis antigen-induced lymphocytes reactivity in human blastomycosis.
    Bradsher RW; Alford RH
    Infect Immun; 1981 Aug; 33(2):485-90. PubMed ID: 7024130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V beta1+ J beta1.1+/V alpha2+ J alpha49+ CD4+ T cells mediate resistance against infection with Blastomyces dermatitidis.
    Wüthrich M; Filutowicz HI; Allen HL; Deepe GS; Klein BS
    Infect Immun; 2007 Jan; 75(1):193-200. PubMed ID: 17030569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of cell surface molecules of Blastomyces dermatitidis in the pathogenesis and immunobiology of blastomycosis.
    Klein BS
    Semin Respir Infect; 1997 Sep; 12(3):198-205. PubMed ID: 9313291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro cell-mediated immune responses to a cell wall antigen of Blastomyces dermatitidis.
    Deighton F; Cox RA; Hall NK; Larsh HW
    Infect Immun; 1977 Feb; 15(2):429-35. PubMed ID: 321349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of an alkali-soluble water-soluble extract of Blastomyces dermatitidis yeast-phase cell walls and isoelectrically focused components in peripheral lymphocyte transformations.
    Hall NK; Deighton F; Larsh HW
    Infect Immun; 1978 Feb; 19(2):411-5. PubMed ID: 631880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of pathogenicity in Blastomyces dermatitidis: the importance of adhesion.
    Klein BS
    Curr Opin Microbiol; 2000 Aug; 3(4):339-43. PubMed ID: 10972490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Western immunoblot analysis and serologic characterization of Blastomyces dermatitidis yeast form extracellular antigens.
    Hurst SF; Kaufman L
    J Clin Microbiol; 1992 Dec; 30(12):3043-9. PubMed ID: 1452683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification in quantity of the secreted form of WI-1: a major adhesin on Blastomyces dermatitidis yeasts.
    Audet R; Brandhorst TT; Klein B
    Protein Expr Purif; 1997 Nov; 11(2):219-26. PubMed ID: 9367819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine antibody response to Blastomyces dermatitidis WI-1 antigen.
    Klein BS; Squires RA; Lloyd JK; Ruge DR; Legendre AM
    Am J Vet Res; 2000 May; 61(5):554-8. PubMed ID: 10803652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis.
    Bariola JR; Hage CA; Durkin M; Bensadoun E; Gubbins PO; Wheat LJ; Bradsher RW
    Diagn Microbiol Infect Dis; 2011 Feb; 69(2):187-91. PubMed ID: 21251563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blastomyces dermatitidis Antibody and Antigen Detection: Comparison of Four Lysate Antigens and Antibodies Prepared from Human Isolates from a Blastomycosis Outbreak.
    Hammon JT; Kennell BC; Scalarone GM
    Mycopathologia; 2019 Oct; 184(5):661-666. PubMed ID: 31583528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of anti-WI-1 adhesin antibody-mediated protection in experimental pulmonary blastomycosis.
    Wüthrich M; Klein BS
    J Infect Dis; 2000 May; 181(5):1720-8. PubMed ID: 10823774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of long-term specific cellular immunity after acute Blastomyces dermatitidis infection: assessments following a large point-source outbreak in Wisconsin.
    Klein BS; Bradsher RW; Vergeront JM; Davis JP
    J Infect Dis; 1990 Jan; 161(1):97-101. PubMed ID: 2295863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The WI-1 adhesin blocks phagocyte TNF-alpha production, imparting pathogenicity on Blastomyces dermatitidis.
    Finkel-Jimenez B; Wüthrich M; Brandhorst T; Klein BS
    J Immunol; 2001 Feb; 166(4):2665-73. PubMed ID: 11160330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.